ArticleFrontiers in oncology2020

Targeting 14-3-3ζ Overcomes Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma via BMP2/Smad/ID1 Signaling.

Jinfang Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.